For veterans and active-duty military
Legal psychedelic therapy pathways for service members.
The 2026 White House Initiative on Psychedelic Medicine opened federal Right to Try access to ibogaine for eligible veterans, directed the VA to expand its ibogaine PTSD trials, and accelerated FDA review of MDMA-assisted therapy. Here is what is actually available today - and how to access it.
- VA-adjacent ibogaine trials
- Recruiting
- VA-adjacent MDMA trials
- Waitlisted
- Tricare Spravato
- Covered for TRD
- Right to Try (ibogaine)
- Eligible (2026)
Four legal pathways
How service members actually access this care
Each pathway has a different eligibility bar, funding source, and risk profile. Start with the one that matches your situation.
Active VA clinical trial
The strongest pathway if you qualify. Free treatment, full supervision, coordinated with your VA psychiatrist. Entry depends on diagnosis (PTSD, TRD, MST), location (NY / CA / OR / AZ depending on the trial), and cohort openings.
See VA trial sitesTricare-covered Spravato
Spravato is generally covered under Tricare Select and Prime when your prescribing psychiatrist documents treatment-resistant depression and prior authorization is granted. Requires a REMS-certified site and the standard 2-hour observation after each dose. Out-of-pocket cost varies by plan tier and region; confirm with your regional Tricare contractor before scheduling.
Find Tricare providersRight to Try (ibogaine)
The 2026 executive order explicitly named ibogaine as an eligible investigational drug under the 2018 federal Right to Try Act. If you have a life-threatening condition (severe TRD with suicidality, treatment-resistant PTSD), your psychiatrist can petition a sponsor for access. No VA referral required, but most patients coordinate with their VA team.
How Right to Try worksLicensed state programs
Oregon and Colorado operate licensed adult-use psilocybin programs. You do not need a diagnosis or referral to book. No insurance coverage (cash only, $2,200-$3,500/session), but many private foundations run veteran scholarships. Colorado's Natural Medicine Health Act explicitly includes a veterans access provision.
See licensed psilocybin providersVA-adjacent trials
Where to look for trials actively recruiting veterans
Veteran-focused psychedelic trials are a moving target - VA-run, VA-collaborating, and academic-partner studies all change enrollment status month to month. Rather than list specific sites that may close or pause between updates, we point to the live registries below.
Authoritative registry
ClinicalTrials.gov
Every FDA-authorized trial, including VA-run and VA-collaborating arms, is registered here. Search for “ibogaine”, “MDMA PTSD veteran”, or “psilocybin veteran” and filter by Recruiting status.
Open ClinicalTrials.govVA research portal
VA Office of Research and Development
The VA ORD maintains a public list of trials its medical centers are running or co-sponsoring. Cross-reference with ClinicalTrials.gov before contacting a site, since the VA list lags real recruitment status.
Open research.va.govAlways confirm recruitment status directly with the study team before scheduling travel. Trial cohorts open and close without public notice.
International retreat comparison
4 ibogaine retreats treating US veterans, compared
Ambio, Beond, Iboga Wellness Center, Clear Sky. Side-by-side cost, cardiac protocol, veteran-specific pricing, and who each retreat is a real fit for.
Tricare network
Providers accepting Tricare for Spravato / ketamine
Coverage depends on your specific plan tier and prior authorization. These clinics have explicitly confirmed they process Tricare claims in-network.
In-network confirmation in progress
We are still verifying Tricare network status clinic-by-clinic.
Tricare coverage for Spravato is plan-specific (Select vs Prime vs Reserve Select) and varies by region. Rather than list clinics that only “probably” take Tricare, we wait for written confirmation from each site’s billing office before adding them. In the meantime, every Spravato-certified REMS site can accept Tricare by submitting a prior auth - the question is network tier and patient cost, not access.
Common questions
Will using psychedelic therapy affect my VA benefits?
Not if you go through an approved pathway. VA-authorized trials, Tricare-covered Spravato, and documented Right to Try access do not trigger benefit reviews or security clearance flags. Self-medication outside these pathways is a different conversation - get a JAG or VSO consult first.
What if I am active duty, not a veteran?
Spravato is generally covered under Tricare Select and Prime for service members with documented TRD, subject to prior authorization and a REMS-certified prescriber; check your specific plan and region. MDMA and ibogaine trials are typically restricted to veterans or civilians currently - check the individual trial's eligibility listing on ClinicalTrials.gov. Accessing licensed Oregon or Colorado psilocybin programs while active-duty is a separate conversation - talk to your command's legal team first.
Is there a veteran-specific scholarship for psilocybin?
Yes. The Heroic Hearts Project, Veterans of War, and the Helmet Group each run veteran scholarships for Oregon or international psilocybin retreats. Colorado's Natural Medicine Act also directs the Natural Medicine Advisory Board to consider veteran and first-responder access; no publicly-funded per-person subsidy has been disbursed yet, so treat any third-party claim of a Colorado-state-paid subsidy as unconfirmed.
Can my VA doctor refer me to a licensed psilocybin program?
They cannot formally refer (federal Schedule I status), but most VA psychiatrists will share prep and integration therapy recommendations, and many can write medical clearance letters the service center will accept at intake. Ask openly - the 2026 executive order explicitly authorized VA staff to discuss state-legal programs with patients.
Policy update
The 2026 executive order, explained
On April 18, 2026, President Trump signed the executive order "Accelerating Medical Treatments for Serious Mental Illness". It directed the FDA to use priority review vouchers for psychedelic submissions, named ibogaine as eligible under Right to Try, allocated $50M through ARPA-H for veteran-focused trials, and ordered the VA to expand site authorization for ibogaine and MDMA studies.
Read the full explainer